# Irofulven in Treating Patients With Metastatic or Recurrent Colorectal Cancer

> **NCT00003786** · PHASE2 · WITHDRAWN · sponsor: **University of Chicago**

## Conditions studied

- Colorectal Cancer

## Interventions

- **DRUG:** irofulven

## Key facts

- **NCT ID:** NCT00003786
- **Lead sponsor:** University of Chicago
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 1999-04
- **Primary completion:** 2000-11
- **Final completion:** 2000-11
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** NO participants
- **Last updated:** 2014-03-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00003786

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00003786, "Irofulven in Treating Patients With Metastatic or Recurrent Colorectal Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00003786. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*